News

C ocrystal Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to ...
Flu changes every year, so our vaccine has to change with it. Here’s the quick what-and-why behind the annual shot, how it’s ...
CDC wastewater also shows the XFG variant — nicknamed stratus — is most common in the U.S. Stratus can cause a “razor blade” sore throat and is considered a “variant under monitoring” by the World ...
If the COVID-19 pandemic taught us one thing, it was the importance of washing our hands.Apparently, not everyone got the ...
The University regularly tests wastewater from 26 sewage junctions in 10 student residential buildings for SARS-CoV-2, influenza A and norovirus. The early warning system was originally implemented in ...
Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-CEO Sam Lee, PhD discussed the scientific foundation ...
Vaxart is building a portfolio of oral vaccines designed to address infectious diseases including norovirus, COVID-19, and influenza. Its lead programs target major public health threats and aim to ...
It was the breakthrough vaccine technology that allowed for the rapid release of COVID-19 vaccines. But as top health officials vilify mRNA use, SC testing goes on in cancer and viruses.
Public health experts say diseases are more likely to tear through crowded storm shelters after the state canceled vaccine ...
Vaxart’s GAAP revenue rose to $39.7 million in Q2 2025, over 18 times analyst estimates, mainly from government contract recognition tied to the COVID-19 trial. Research and development expense grew ...